Scinovex
article Open AccessTop 1% cited

Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy · 1995 · Vol. 39(9) · pp. 1948–1953
Xiujuan LiHiroshi NikaidoKeith Poole

Abstract

We have earlier described mexA-mexB-oprK, an operon involved in pyoverdine export in Pseudomonas aeruginosa, and suggested that the products of these genes also contribute to the active efflux of several antibiotics (K. Poole, K. Krebes, C. McNally, and S. Neshat, J. Bacteriol. 175:7363-7372, 1993). Recently the outer membrane component of this efflux system was shown to be OprM, rather than OprK (N. Gotoh and K. Poole, unpublished results). In the present study, the conclusion concerning the efflux activity of this system was confirmed and extended by the measurement of drug accumulation in intact cells. Thus, the steady-state accumulation levels of tetracycline and norfloxacin were increased in mexA and oprM null mutants. mexA and oprM null mutants also showed an increase in susceptibility to a wide variety of beta-lactam antibiotics and an increase in the steady-state accumulation level of benzylpenicillin, indicating that the MexA-MexB-OprM pump also effluxes beta-lactams. Furthermore, deenergization of the cytoplasmic membrane with a proton conductor always produced a strong increase in the accumulation level. Finally, a single-step mutant over-producing MexAB-OprM accumulated less tetracycline and chloramphenicol than the parent strain and was more resistant to a wide range of antimicrobial compounds, including beta-lactams. These results support the notion that these proteins contribute to the intrinsic resistance of P. aeruginosa through the multidrug active efflux process.

Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyDrug Transport and Resistance MechanismsEffluxPseudomonas aeruginosaChloramphenicolMicrobiologyTetracyclineMutantAntibioticsBiologyBacterial outer membraneChemistry

MeSH terms

Anti-Infective AgentsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsChloramphenicolDNA Transposable ElementsMicrobial Sensitivity TestsNorfloxacinOperonPenicillin GPenicillinsPseudomonas aeruginosaTetracycline

Funding

  • Medical Research Council Canada
  • U.S. Public Health Service
  • Medical Research Council
Citations
633
FWCI
11.01
field-weighted impact
References
27
Percentile
99%
vs. same field & year
Citations per year
Cited by
Multidrug efflux pumps of gram-negative bacteria
Journal of Bacteriology · 1996 · 1,082 citations
Riddle of Biofilm Resistance
Antimicrobial Agents and Chemotherapy · 2001 · 1,960 citations
Three Decades of β-Lactamase Inhibitors
Clinical Microbiology Reviews · 2010 · 1,608 citations
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Clinical Microbiology Reviews · 2015 · 1,520 citations
Active efflux, a common mechanism for biocide and antibiotic resistance
Journal of Applied Microbiology · 2002 · 397 citations
Efflux-Mediated Drug Resistance in Bacteria
Drugs · 2009 · 924 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.